FDA greenlights 23andMe’s request to market direct-to-consumer genetic health risk reports

Genetic risk reports for Alzheimer's disease, Parkinson's disease and Hereditary Thrombophilia included in the FDA authorization, among others.
Face2Gene RESEARCH app screen

FDNA’s Face2Gene RESEARCH uses computer vision to accelerate genomic discoveries

The application enables clinicians all around the world to make rare and genetic disease discoveries using deep learning and artificial intelligence.
Dr. Patrick Soon-Shiong

NantHealth looking to raise $92M in an IPO

The Culver City, California-based company has developed a platform, called CLINICS, to address many of the key challenges healthcare constituents face.
Vitruvian Networks

Mayo Clinic, GE Ventures to bring IoT to cell and gene therapies

Vitruvian Networks, will serve as a network orchestrator for therapeutic companies with powerful business intelligence and data analytics capabilities.
patient support

Trial to use genetic data, sensors to diagnose Parkinson’s disease

Called GADGET-PD, the trial will use wireless sensors and genetic sequencing to determine if a patient has essential tremor (ET) from Parkinson's disease (PD).

Apple ResearchKit updated with support for genetic data

Researchers are now able to design targeted studies for diseases and conditions, and to gather more specific types of data from participants.
Knome knoSYS

Tute Genomics acquires Knome to boost its genomics tech

Knome's knoSYS tech brings maximum value to the already robust genome informatics offerings at Tute, used by many of the top institutions across the world.

23andMe launches new FDA-cleared service

Called Personal Genome Service, it is touted as an entirely new experience that includes carrier status, wellness, trait and ancestry reports.

23andMe secures $115M Series E round led by Fidelity Management & Research Company

The new funds will help the personal genetics company launch new global user experience, grow its sales efforts and therapeutics discovery group efforts.
PathwayFit Promo

Pathway Genomics launches $99 genetic test

The Pathway Fit genetic test analyzes over 75 genetic markers known to impact metabolism, exercise, and energy consumption use within the human body.